WO2018072213A1 - 一种酶法制备瑞鲍迪甙n的方法 - Google Patents
一种酶法制备瑞鲍迪甙n的方法 Download PDFInfo
- Publication number
- WO2018072213A1 WO2018072213A1 PCT/CN2016/102948 CN2016102948W WO2018072213A1 WO 2018072213 A1 WO2018072213 A1 WO 2018072213A1 CN 2016102948 W CN2016102948 W CN 2016102948W WO 2018072213 A1 WO2018072213 A1 WO 2018072213A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ugt
- sequence
- udp
- amino acid
- rebaudioside
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 35
- 229930188195 rebaudioside Natural products 0.000 title claims abstract description 31
- 238000006911 enzymatic reaction Methods 0.000 title claims abstract description 8
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims abstract description 24
- 239000000758 substrate Substances 0.000 claims abstract description 13
- HINSNOJRHFIMKB-DJDMUFINSA-N [(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl] (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate Chemical compound [H][C@@]1(O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC(=O)[C@]2(C)CCC[C@@]3(C)[C@]4([H])CC[C@@]5(C[C@]4(CC5=C)CC[C@]23[H])O[C@]2([H])O[C@H](CO)[C@@H](O)[C@H](O[C@]3([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]2O[C@]2([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O HINSNOJRHFIMKB-DJDMUFINSA-N 0.000 claims abstract description 11
- 239000001512 FEMA 4601 Substances 0.000 claims abstract description 10
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 claims abstract description 10
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000019203 rebaudioside A Nutrition 0.000 claims abstract description 10
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 7
- 239000000348 glycosyl donor Substances 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims description 52
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 30
- 241000544066 Stevia Species 0.000 claims description 15
- 229930006000 Sucrose Natural products 0.000 claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 10
- 239000005720 sucrose Substances 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 9
- 239000000386 donor Substances 0.000 claims description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims description 7
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 claims description 7
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 claims description 6
- 235000009566 rice Nutrition 0.000 claims description 6
- 230000008929 regeneration Effects 0.000 claims description 5
- 238000011069 regeneration method Methods 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 108010043934 Sucrose synthase Proteins 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 239000008346 aqueous phase Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 241000235058 Komagataella pastoris Species 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 2
- DRDCJEIZVLVWNC-SLBWPEPYSA-N UDP-beta-L-rhamnose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 DRDCJEIZVLVWNC-SLBWPEPYSA-N 0.000 claims description 2
- 230000000149 penetrating effect Effects 0.000 claims description 2
- 239000008055 phosphate buffer solution Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 125000003944 tolyl group Chemical group 0.000 claims description 2
- 239000008191 permeabilizing agent Substances 0.000 claims 1
- 239000008176 lyophilized powder Substances 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- XCCTYIAWTASOJW-XVFCMESISA-N Uridine-5'-Diphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 XCCTYIAWTASOJW-XVFCMESISA-N 0.000 description 11
- 239000012634 fragment Substances 0.000 description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 101000630755 Arabidopsis thaliana Sucrose synthase 1 Proteins 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- 241000209094 Oryza Species 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 235000019202 steviosides Nutrition 0.000 description 4
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229940013618 stevioside Drugs 0.000 description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 108700023372 Glycosyltransferases Proteins 0.000 description 2
- 102000051366 Glycosyltransferases Human genes 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000007036 catalytic synthesis reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
- C12P19/08—Dextran
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01017—Glucuronosyltransferase (2.4.1.17)
Definitions
- the invention relates to a preparation method of rebaudioside N, in particular to a biological preparation method of rebaudioside N.
- Sweeteners are a class of food additives that are widely used in the production of foods such as beverages and confectionery. They can be added during the production of foods or appropriately diluted as a substitute for sucrose during home baking. Sweeteners include natural sweeteners and artificial sweeteners, the former including sucrose, high fructose corn syrup, honey, and the like, the latter including aspartame, saccharin, and the like.
- Stevia is a natural sweetener extracted from plant stevia and is currently widely used in foods and beverages. The extract of Stevia has a variety of steviosides including rebaudioside, and the different batch components of naturally extracted stevioside vary greatly, requiring subsequent purification.
- the ratio of rebaudioside in stevia leaves is less than 1.5%. It is extremely difficult to obtain high-purity Rebaudioside N by traditional extraction methods, which limits the in-depth study of Rebaudio N and hinders Its commercial application.
- the technical problem to be solved by the present invention is to overcome the deficiencies of the prior art and provide a method for preparing rebaudioside N by enzymatic method, which can produce high purity rebaudioside at a low cost and in a short cycle. N product.
- the present invention adopts the following technical solutions:
- the glycosyl donor comprises one or two of a glucose-based donor, a rhamnosyl donor, UDP-glucose or UDP consisting of sucrose, sucrose synthase and UDP.
- a rhamnose donor is UDP-rhamnose.
- a UDP-glucose regeneration system composed of sucrose, sucrose synthase, and UDP is preferred, and UDP glucose is expensive, and the cost can be greatly reduced by the UDP-glucose regeneration system.
- the UDP-glycosyltransferase ie uridine diphosphate glucosyltransferase, abbreviated UGT, is known
- UGT uridine diphosphate glucosyltransferase
- It includes one or two of UGT-A from Stevia rebaudiana and UGT-B from rice (Oryza sativa).
- the UDP-glycosyltransferase comprises UGT-A from Stevia and UGT-B from rice; the UDP-glycosyltransferase is added to the reaction system in two steps, and the first step is to add UGT- B, the second step is to join UGT-A.
- the amino acid sequence of UGT-A has at least 60% identity with sequence 2 shown in the sequence listing; and/or the amino acid sequence of UGT-B has at least 60% with sequence 4 shown in the sequence listing. Consistency.
- the amino acid sequence of the UGT-A is at least 70% identical to the sequence 2 shown in the sequence listing; and/or the amino acid sequence of the UGT-B and the sequence 4 shown in the sequence listing. Has at least 70% consistency.
- amino acid sequence of the UGT-A has at least 80% identity with the sequence 2 shown in the sequence listing; and/or, the amino acid sequence of the UGT-B has the sequence 4 shown in the sequence listing. At least 80% consistency.
- amino acid sequence of the UGT-A has at least 90% identity with the sequence 2 shown in the sequence listing; and/or the amino acid sequence of the UGT-B and the sequence 4 shown in the sequence listing Has at least 90% consistency.
- amino acid sequence of UGT-A is identical to sequence 2 shown in the sequence listing; and/or the amino acid sequence of UGT-B is identical to sequence 4 shown in the sequence listing. .
- the UDP-glycosyltransferase is UGT-A from Stevia, the amino acid sequence of the UGT-A having at least 60% identity to the sequence 2 shown in the Sequence Listing.
- amino acid sequence of UGT-A is at least 70% identical to sequence 2 shown in the Sequence Listing.
- amino acid sequence of UGT-A has at least 80% identity to sequence 2 shown in the sequence listing.
- amino acid sequence of UGT-A has at least 90% identity to sequence 2 shown in the sequence listing.
- amino acid sequence of UGT-A is identical to sequence 2 shown in the Sequence Listing.
- the reaction can be carried out in an aqueous phase system at a temperature of 4 to 50 ° C and a pH of 5.0 to 9.0.
- the reaction is carried out in an aqueous phase system at a temperature of 35-45 ° C and a pH of 7.5-8.5.
- reaction is carried out in a phosphate buffer solution.
- the reaction system contains a recombinant cell of UDP-glycosyltransferase and a cell permeable agent.
- the cell penetrating agent is toluene, and the volume ratio of toluene in the reaction system is 1-3%.
- Rebaudio N product that meets the requirements for use can be obtained by purification treatment.
- a specific purification method is post-treatment including separation of the resin, according to which the rebaudioside having a purity of up to 95% can be obtained. N product.
- the recombinant cell is a microbial cell. More preferably, the microorganism is Escherichia coli, Saccharomyces cerevisiae or Pichia pastoris.
- the first step reaction substrate is rebaudioside A
- the UDP-glycosyltransferase is UGT-B from rice
- the amino acid sequence of UGT-B from rice has at least 80 % consistency
- the second step reaction substrate is a reaction solution containing the first step reaction product Rebaudioside J
- the UDP-glycosyltransferase is UGT-A from Stevia
- the amino acid sequence of UGT-A from Stevia has at least 80% consistency.
- the substrate is Rebaudioside J
- the UDP-glycosyltransferase is UGT-A from Stevia
- the amino acid sequence of UGT-A from Stevia has at least 80% consistency.
- the present invention has the following advantages compared with the prior art:
- the method for preparing rebaudioside N by the enzymatic method provided by the invention has important application value. Since the growth rate of microorganisms is much faster than that of plants, the method can greatly reduce the production cost, shorten the production cycle, and greatly improve the competitiveness of the product. In addition, the stevia content in plants is low, and there are many different structures of stevioside, it is difficult to extract a relatively pure product, compared with the technique of extracting rebaudioside N from stevia leaves, the invention is The enzymatic synthesis method can provide higher purity products, and will certainly promote the research and application of the new stevioside rebaudioside N.
- the invention mainly provides two routes for synthesizing Rebaudio N:
- the UGT-A or UGT-B used in the present invention may be present in the form of an enzyme lyophilized powder or present in recombinant cells.
- UGT-A or UGT-B can be obtained as follows:
- Recombinant Escherichia coli (or other microbial) expression strains of UGT-A or UGT-B were obtained by molecular cloning technology and genetic engineering technology, and then recombinant Escherichia coli was fermented to prepare UGT-A or UGT.
- -B recombinant cells, or lyophilized powder of UGT-A or UGT-B prepared from the above recombinant cells.
- the recombinant plasmid was transformed into Escherichia coli BL21 (DE3), and the expression of the target protein was induced by IPTG to obtain a recombinant Escherichia coli expression strain of UGT-A or UGT-B.
- the recombinant Escherichia coli expression strain containing UGT-A or UGT-B was inoculated into 4 ml of liquid LB medium at a ratio of 1%, shake culture (200 rpm) overnight at 37 ° C, and the overnight culture was inoculated at 1%. Transfer to 50 ml of liquid LB medium, shake culture (200 rpm) at 37 ° C until the OD600 value reached 0.6-0.8, and incubate at a final concentration of 0.4 mM IPTG at 20 ° C overnight.
- the cells were collected by centrifugation (8,000 rpm, 10 min), and the cells were resuspended in 5 ml of 2 mmol/L phosphate buffer (pH 7.0) to obtain the recombinant cells, and the cells were further ultrasonically disrupted in an ice bath, and the disrupted solution was centrifuged ( 8,000 rpm, 10 min), the supernatant was collected and lyophilized for 24 h to obtain the lyophilized powder.
- phosphate buffer pH 7.0
- Example 1 Preparation of recombinant E. coli cells containing UGT-A
- the UGT strain was inoculated into 4 ml of liquid LB medium at a ratio of 1%, shake culture (200 rpm) overnight at 37 ° C, and the overnight culture was transferred to 50 ml of liquid LB medium at a 1% inoculum and shake cultured at 37 ° C (200 rpm).
- the OD 600 value was 0.6-0.8, and the final concentration of 0.4 mM IPTG was added to shake culture at 20 ° C overnight.
- the cells were collected by centrifugation (8,000 rpm, 10 min), and the cells were resuspended in 5 ml of 2 mmol/L phosphate buffer (pH 7.0) to obtain recombinant cells containing UGT-A for catalysis.
- the recombinant cells of UGT-A prepared in Example 1 were ultrasonically disrupted in an ice bath, and the disrupted solution was centrifuged (8,000 rpm, 10 min), and the supernatant was collected and lyophilized for 24 hours to obtain a lyophilized powder of UGT-A.
- the UGT strain was inoculated into 4 ml of liquid LB medium at a ratio of 1%, shake culture (200 rpm) overnight at 37 ° C, and the overnight culture was transferred to 50 ml of liquid LB medium at a 1% inoculum and shake cultured at 37 ° C (200 rpm).
- the OD 600 value was 0.6-0.8, and the final concentration of 0.4 mM IPTG was added to shake culture at 20 ° C overnight.
- the cells were collected by centrifugation (8,000 rpm, 10 min), and the cells were resuspended in 5 ml of 2 mmol/L phosphate buffer (pH 7.0) to obtain recombinant cells containing UGT-B for catalysis.
- the recombinant cells of UGT-B prepared in Example 3 were ultrasonically disrupted in an ice bath, and the disrupted solution was centrifuged (8,000 rpm, 10 min), and the supernatant was collected and lyophilized for 24 hours to obtain a lyophilized powder of UGT-B.
- the UGT-A lyophilized powder prepared according to the method of Example 2 was used to catalyze the synthesis of Rebaudioside N.
- sucrose, a sucrose synthase derived from Arabidopsis thaliana (hereinafter referred to as AtSUS1), and a UDP-glucose regeneration system composed of UDP were used as the glucosyl donor.
- the conversion rate of rebaudioside J is over 90%. After purification by silica gel resin, crystallization and the like, it was purified to obtain Rebaudioside N 0.61 g, and the purity was more than 95%.
- the UGT-A lyophilized powder prepared according to the method of Example 2 and the UGT-B lyophilized powder prepared according to the method of Example 4 were used for catalytic synthesis of Rebaudioside N.
- the first step reaction 1L 0.05mol/L phosphate buffer (pH 8.0), 2g UDP rhamnose, 1g rebaudioside A, UGT-B lyophilized powder 10g are uniformly added to the reaction system and then placed in 40 The reaction was stirred for 24 h at 300 rpm in a water bath.
- the second step reaction after the first step, the reaction solution is boiled for 10 min, the pH is adjusted to 8.0, 0.5 g UDP, 5 g of sucrose, 10 g of UGT-A lyophilized powder, and 3 g of AtSUS1 lyophilized powder are uniformly mixed and placed. The reaction was stirred at 300 rpm for 24 h in a 40 ° C water bath.
- Example 7 Synthesis of Rebaudi under the catalysis of recombinant cells containing UDP-glycosyltransferase using Rebaudioside J as substrate ⁇ N
- Example 8 Synthesis of Rebaudi under the catalysis of recombinant cells containing UDP-glycosyltransferase using Rebaudioside A as substrate ⁇ N
- First step reaction 1L 0.05mol/L phosphate buffer (pH 8.0), 2g UDP rhamnose, 1g rebaudioside A, UTG-B whole cell 40g were mixed and evenly placed in the reaction system and then placed at 40 °C. The reaction was stirred for 24 h at 300 rpm in a water bath.
- the second step reaction After the first step, the reaction solution is boiled for 10 minutes, the pH is adjusted to 8.0, 0.5 g UDP, 5 g of sucrose, 40 g of UGT-A whole cells, and 10 g of AtSUS1 whole cells are uniformly mixed and placed at 40 ° C. The reaction was stirred for 24 h at 300 rpm in a water bath.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (20)
- 一种酶法制备瑞鲍迪甙N的方法,其特征在于:以瑞鲍迪甙A为底物,在糖基供体存在下,在含有UDP-糖基转移酶的重组细胞和/或其制备的UDP-糖基转移酶的催化下,反应生成瑞鲍迪甙N。
- 一种酶法制备瑞鲍迪甙N的方法,其特征在于:以瑞鲍迪甙J为底物,在糖基供体存在下,在含有UDP-糖基转移酶的重组细胞和/或其制备的UDP-糖基转移酶的催化下,反应生成瑞鲍迪甙N。
- 根据权利要求1或2所述的方法,其特征在于:所述糖基供体包括葡萄糖基供体、鼠李糖基供体中一种或二种,所述葡萄糖基供体为UDP-葡萄糖或由蔗糖、蔗糖合成酶及UDP组成的UDP-葡萄糖再生体系,所述鼠李糖基供体为UDP-鼠李糖。
- 根据权利要求1或2所述的方法,其特征在于:所述UDP-糖基转移酶包括来自甜菊的UGT-A、来自水稻的UGT-B中的一种或二种。
- 根据权利要求1所述的方法,其特征在于:所述UDP-糖基转移酶包括来自甜菊的UGT-A和来自水稻的UGT-B;所述UDP-糖基转移酶分两步加入到反应体系中,第一步先加入UGT-B,第二步再加入UGT-A。
- 根据权利要求5所述的方法,其特征在于:所述UGT-A的氨基酸序列与序列表中所示的序列2具有至少60%的一致性;和/或,所述UGT-B的氨基酸序列与序列表中所示的序列4具有至少60%的一致性。
- 根据权利要求6所述的方法,其特征在于:所述UGT-A的氨基酸序列与序列表中所示的序列2具有至少70%的一致性;和/或,所述UGT-B的氨基酸序列与序列表中所示的序列4具有至少70%的一致性。
- 根据权利要求7所述的方法,其特征在于:所述UGT-A的氨基酸序列与序列表中所示的序列2具有至少80%的一致性;和/或,所述UGT-B的氨基酸序列与序列表中所示的序列4具有至少80%的一致性。
- 根据权利要求8所述的方法,其特征在于:所述UGT-A的氨基酸序列与序列表中所示的序列2具有至少90%的一致性;和/或,所述UGT-B的氨基酸序列与序列表中所示的序列4具有至少90%的一致性。
- 根据权利要求2所述的方法,其特征在于:所述UDP-糖基转移酶为来自甜菊的 UGT-A,所述UGT-A的氨基酸序列与序列表中所示的序列2具有至少60%的一致性。
- 根据权利要求10所述的方法,其特征在于:所述UGT-A的氨基酸序列与序列表中所示的序列2具有至少70%的一致性。
- 根据权利要求11所述的方法,其特征在于:所述UGT-A的氨基酸序列与序列表中所示的序列2具有至少80%的一致性。
- 根据权利要求12所述的方法,其特征在于:所述UGT-A的氨基酸序列与序列表中所示的序列2具有至少90%的一致性。
- 根据权利要求1或2所述的方法,其特征在于:反应在35-45℃温度以及pH7.5-8.5的水相体系中进行。
- 根据权利要求14所述的方法,其特征在于:反应在磷酸缓冲溶液中进行。
- 根据权利要求14所述的方法,其特征在于:反应体系含有UDP-糖基转移酶的重组细胞和细胞通透剂。
- 根据权利要求16所述的方法,其特征在于:所述细胞通透剂为甲苯,甲苯在反应体系中的体积比浓度为1-3%。
- 根据权利要求14所述的方法,其特征在于:将反应所用全部原料加入到反应釜中,混合均匀后置于设定温度下,搅拌反应。
- 根据权利要求1或2所述的方法,其特征在于:所述重组细胞为微生物细胞。
- 根据权利要求19所述的方法,其特征在于:所述微生物为大肠埃希氏杆菌、酿酒酵母或毕赤酵母。
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310412340.4A CN116515929A (zh) | 2016-10-21 | 2016-10-21 | 一种酶法制备瑞鲍迪甙n的方法 |
EP16919469.3A EP3530745A4 (en) | 2016-10-21 | 2016-10-21 | PROCESS FOR PREPARING REBAUDIOSIDE N USING AN ENZYMATIC PROCESS |
CA3041152A CA3041152A1 (en) | 2016-10-21 | 2016-10-21 | Method for preparing rebaudioside n using enzymatic method |
BR112019008048A BR112019008048A2 (pt) | 2016-10-21 | 2016-10-21 | método para preparar rebaudiosídeo n com o uso de método enzimático |
RU2019112909A RU2737118C2 (ru) | 2016-10-21 | 2016-10-21 | Способ получения ребаудиозида n с применением ферментативного способа |
AU2016427130A AU2016427130B2 (en) | 2016-10-21 | 2016-10-21 | Method for preparing rebaudioside N using enzymatic method |
MX2019004628A MX2019004628A (es) | 2016-10-21 | 2016-10-21 | Metodo para preparar rebaudiosido n usando el metodo enzimatico. |
JP2019520995A JP6972123B2 (ja) | 2016-10-21 | 2016-10-21 | 酵素法を使用するレバウディオサイドnを調製するための方法 |
CN201680089986.1A CN109890973B (zh) | 2016-10-21 | 2016-10-21 | 一种酶法制备瑞鲍迪甙n的方法 |
PCT/CN2016/102948 WO2018072213A1 (zh) | 2016-10-21 | 2016-10-21 | 一种酶法制备瑞鲍迪甙n的方法 |
US16/343,335 US11352653B2 (en) | 2016-10-21 | 2016-10-21 | Enzymatic method for preparing rebaudioside N |
US17/663,631 US11976313B2 (en) | 2016-10-21 | 2022-05-16 | Enzymatic method for preparing rebaudioside N |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2016/102948 WO2018072213A1 (zh) | 2016-10-21 | 2016-10-21 | 一种酶法制备瑞鲍迪甙n的方法 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/343,335 A-371-Of-International US11352653B2 (en) | 2016-10-21 | 2016-10-21 | Enzymatic method for preparing rebaudioside N |
US17/663,631 Continuation US11976313B2 (en) | 2016-10-21 | 2022-05-16 | Enzymatic method for preparing rebaudioside N |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018072213A1 true WO2018072213A1 (zh) | 2018-04-26 |
Family
ID=62018053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2016/102948 WO2018072213A1 (zh) | 2016-10-21 | 2016-10-21 | 一种酶法制备瑞鲍迪甙n的方法 |
Country Status (10)
Country | Link |
---|---|
US (2) | US11352653B2 (zh) |
EP (1) | EP3530745A4 (zh) |
JP (1) | JP6972123B2 (zh) |
CN (2) | CN109890973B (zh) |
AU (1) | AU2016427130B2 (zh) |
BR (1) | BR112019008048A2 (zh) |
CA (1) | CA3041152A1 (zh) |
MX (1) | MX2019004628A (zh) |
RU (1) | RU2737118C2 (zh) |
WO (1) | WO2018072213A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022524214A (ja) * | 2019-03-29 | 2022-04-28 | コナゲン インコーポレイテッド | Udp-ラムノースの生合成生産 |
WO2022233948A1 (en) | 2021-05-05 | 2022-11-10 | Hypex Bio Explosives Technology Ab | Composition for forming a hydrogen peroxide based emulsion explosive |
EP4170025A1 (en) * | 2021-10-19 | 2023-04-26 | CJ Cheiljedang Corporation | Novel uridine diphosphate glycosyltransferase and use thereof |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116574775A (zh) | 2016-10-21 | 2023-08-11 | 百事可乐公司 | 一种酶法制备瑞鲍迪甙j的方法 |
JP2019532650A (ja) | 2016-10-21 | 2019-11-14 | ペプシコ・インク | 酵素法を使用することによりレバウディオサイドcを調製するための方法 |
KR20210027270A (ko) * | 2018-06-08 | 2021-03-10 | 퓨어써클 유에스에이 잉크. | 고순도 스테비올 글리코사이드 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103397064A (zh) * | 2013-08-14 | 2013-11-20 | 苏州汉酶生物技术有限公司 | 一种酶法制备瑞鲍迪甙m的方法 |
CN103757074A (zh) * | 2014-01-16 | 2014-04-30 | 苏州汉酶生物技术有限公司 | 一种酶法制备瑞鲍迪甙m的方法 |
CN103974628A (zh) * | 2012-05-22 | 2014-08-06 | 谱赛科有限责任公司 | 高纯度的甜菊醇糖苷 |
WO2015065650A2 (en) * | 2013-11-01 | 2015-05-07 | Conagen Inc. | Recombinant production of steviol glycosides |
CN105200098A (zh) * | 2015-06-30 | 2015-12-30 | 苏州汉酶生物技术有限公司 | 一种利用酿酒酵母酶法制备瑞鲍迪甙m的方法 |
CN105492453A (zh) * | 2013-05-28 | 2016-04-13 | 可口可乐公司 | 高纯度的甜菊醇糖苷 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5307730B2 (ja) | 2007-01-22 | 2013-10-02 | カーギル・インコーポレイテッド | 溶媒/貧溶媒晶析を用いる精製レバウディオサイドa組成物の製法 |
CN101225424B (zh) | 2007-09-13 | 2013-05-29 | 天津药物研究院 | 环黄芪醇的单葡萄糖苷、其制备方法、药物组合物和应用 |
KR101918422B1 (ko) | 2008-10-03 | 2018-11-13 | 모리타 가가쿠 고교 가부시키가이샤 | 신규 스테비올 배당체 |
EP2358730B1 (en) | 2009-10-15 | 2014-01-15 | Purecircle SDN BHD | Method for preparing high-purity rebaudioside d |
CN105671108A (zh) | 2010-06-02 | 2016-06-15 | 沃维公司 | 甜菊糖苷的重组生产 |
US8962698B2 (en) | 2011-01-28 | 2015-02-24 | Tate & Lyle Ingredients Americas Llc | Rebaudioside-mogroside V blends |
EP3009508B1 (en) | 2011-08-08 | 2020-11-25 | Evolva SA | Recombinant production of steviol glycosides |
CN103031283B (zh) | 2011-10-08 | 2015-07-08 | 成都华高瑞甜科技有限公司 | 甜叶菊酶vi及莱鲍迪苷a转化为莱鲍迪苷d的方法 |
CN103159808B (zh) | 2011-12-09 | 2017-03-29 | 上海泓博智源医药股份有限公司 | 一种制备天然甜味剂的工艺方法 |
ES2971273T3 (es) | 2011-12-19 | 2024-06-04 | Coca Cola Co | Bebida que comprende rebaudiósido X |
CN104203005A (zh) | 2012-01-23 | 2014-12-10 | 帝斯曼知识产权资产管理有限公司 | 二萜的生产 |
WO2014086890A1 (en) | 2012-12-05 | 2014-06-12 | Evolva Sa | Steviol glycoside compositions sensory properties |
CN103088041B (zh) | 2013-01-29 | 2015-01-07 | 江南大学 | 一种可用于高效生产角质酶的角质酶基因及其应用 |
CN105051195B (zh) | 2013-02-06 | 2019-09-06 | 埃沃尔瓦公司 | 用于提高莱鲍迪苷d和莱鲍迪苷m之产生的方法 |
US9717267B2 (en) | 2013-03-14 | 2017-08-01 | The Coca-Cola Company | Beverages containing rare sugars |
JP2016527905A (ja) * | 2013-08-15 | 2016-09-15 | カーギル・インコーポレイテッド | レバウドシドnを組み込む甘味料及び甘味を付与した組成物 |
SG2013092820A (en) | 2013-12-16 | 2015-07-30 | Ngee Ann Polytechnic | Xylose isomerase genes for xylose-fermenting yeast construction |
JP6541159B2 (ja) | 2014-01-28 | 2019-07-10 | ペプシコ, インコーポレイテッドPepsiCo Inc. | 酵素法を使用することによりレバウディオサイドmを調製する方法 |
US9522929B2 (en) | 2014-05-05 | 2016-12-20 | Conagen Inc. | Non-caloric sweetener |
CN114052237A (zh) | 2014-08-19 | 2022-02-18 | 谱赛科有限责任公司 | 制备莱鲍迪苷i的方法以及用途 |
JP6774945B2 (ja) | 2014-10-03 | 2020-10-28 | コナゲン インコーポレイテッド | ノンカロリー甘味料および合成するための方法 |
SG11201705606PA (en) * | 2015-01-30 | 2017-08-30 | Evolva Sa | Production of steviol glycosides in recombinant hosts |
CN107613786A (zh) | 2015-05-29 | 2018-01-19 | 嘉吉公司 | 产生糖苷的热处理 |
US20190203244A1 (en) | 2015-08-20 | 2019-07-04 | Pepsico, Inc. | Preparation of rebaudioside m in a single reaction vessel |
CN116574775A (zh) | 2016-10-21 | 2023-08-11 | 百事可乐公司 | 一种酶法制备瑞鲍迪甙j的方法 |
JP2019532650A (ja) | 2016-10-21 | 2019-11-14 | ペプシコ・インク | 酵素法を使用することによりレバウディオサイドcを調製するための方法 |
-
2016
- 2016-10-21 JP JP2019520995A patent/JP6972123B2/ja active Active
- 2016-10-21 EP EP16919469.3A patent/EP3530745A4/en active Pending
- 2016-10-21 CA CA3041152A patent/CA3041152A1/en active Pending
- 2016-10-21 MX MX2019004628A patent/MX2019004628A/es unknown
- 2016-10-21 CN CN201680089986.1A patent/CN109890973B/zh active Active
- 2016-10-21 AU AU2016427130A patent/AU2016427130B2/en active Active
- 2016-10-21 WO PCT/CN2016/102948 patent/WO2018072213A1/zh unknown
- 2016-10-21 RU RU2019112909A patent/RU2737118C2/ru active
- 2016-10-21 US US16/343,335 patent/US11352653B2/en active Active
- 2016-10-21 CN CN202310412340.4A patent/CN116515929A/zh active Pending
- 2016-10-21 BR BR112019008048A patent/BR112019008048A2/pt not_active Application Discontinuation
-
2022
- 2022-05-16 US US17/663,631 patent/US11976313B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103974628A (zh) * | 2012-05-22 | 2014-08-06 | 谱赛科有限责任公司 | 高纯度的甜菊醇糖苷 |
CN105492453A (zh) * | 2013-05-28 | 2016-04-13 | 可口可乐公司 | 高纯度的甜菊醇糖苷 |
CN103397064A (zh) * | 2013-08-14 | 2013-11-20 | 苏州汉酶生物技术有限公司 | 一种酶法制备瑞鲍迪甙m的方法 |
WO2015065650A2 (en) * | 2013-11-01 | 2015-05-07 | Conagen Inc. | Recombinant production of steviol glycosides |
CN103757074A (zh) * | 2014-01-16 | 2014-04-30 | 苏州汉酶生物技术有限公司 | 一种酶法制备瑞鲍迪甙m的方法 |
CN105200098A (zh) * | 2015-06-30 | 2015-12-30 | 苏州汉酶生物技术有限公司 | 一种利用酿酒酵母酶法制备瑞鲍迪甙m的方法 |
Non-Patent Citations (2)
Title |
---|
FEBS LETTERS, vol. 581, 2007, pages 2562 - 2566 |
See also references of EP3530745A4 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022524214A (ja) * | 2019-03-29 | 2022-04-28 | コナゲン インコーポレイテッド | Udp-ラムノースの生合成生産 |
JP7318989B2 (ja) | 2019-03-29 | 2023-08-01 | コナゲン インコーポレイテッド | Udp-ラムノースの生合成生産 |
WO2022233948A1 (en) | 2021-05-05 | 2022-11-10 | Hypex Bio Explosives Technology Ab | Composition for forming a hydrogen peroxide based emulsion explosive |
EP4170025A1 (en) * | 2021-10-19 | 2023-04-26 | CJ Cheiljedang Corporation | Novel uridine diphosphate glycosyltransferase and use thereof |
Also Published As
Publication number | Publication date |
---|---|
CN109890973A (zh) | 2019-06-14 |
AU2016427130A1 (en) | 2019-05-30 |
US11352653B2 (en) | 2022-06-07 |
CA3041152A1 (en) | 2018-04-26 |
BR112019008048A2 (pt) | 2019-07-02 |
CN109890973B (zh) | 2023-05-23 |
US20220275415A1 (en) | 2022-09-01 |
EP3530745A1 (en) | 2019-08-28 |
EP3530745A4 (en) | 2020-07-22 |
JP6972123B2 (ja) | 2021-11-24 |
JP2019531083A (ja) | 2019-10-31 |
RU2737118C2 (ru) | 2020-11-24 |
RU2019112909A (ru) | 2020-11-23 |
AU2016427130B2 (en) | 2022-08-18 |
US11976313B2 (en) | 2024-05-07 |
RU2019112909A3 (zh) | 2020-11-23 |
US20210214761A1 (en) | 2021-07-15 |
CN116515929A (zh) | 2023-08-01 |
MX2019004628A (es) | 2019-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10428364B2 (en) | Enzymatic method for preparing rebaudioside M | |
WO2018072213A1 (zh) | 一种酶法制备瑞鲍迪甙n的方法 | |
WO2017000366A1 (zh) | 一种利用酿酒酵母酶法制备瑞鲍迪甙m的方法 | |
JP2017504341A (ja) | 酵素法を使用することによりレバウディオサイドmを調製する方法 | |
US11952604B2 (en) | Enzymatic method for preparing Rebaudioside J | |
US11976312B2 (en) | Enzymatic method for preparing Rebaudioside C | |
JP2019532650A5 (zh) | ||
JP7210626B2 (ja) | 酵素的方法を使用してレバウディオサイドjを調製するための方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16919469 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 3041152 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2019520995 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112019008048 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2016919469 Country of ref document: EP Effective date: 20190521 |
|
ENP | Entry into the national phase |
Ref document number: 2016427130 Country of ref document: AU Date of ref document: 20161021 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 112019008048 Country of ref document: BR Kind code of ref document: A2 Effective date: 20190418 |